Neuroprotection in glaucoma

Journal of Postgraduate Medicine

Volumn 49, Issue 1, 2003, Pages 90-95

  Kaushik, S ^a   Pandav, S S ^a   Ram, J ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; Glaucomatous neuropathy; Neuroprotection; RGC death

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIGLAUCOMA AGENT; ANTIOXIDANT; ASCORBIC ACID; AURINTRICARBOXYLIC ACID; BETAXOLOL; BRAIN DERIVED NEUROTROPHIC FACTOR; BRIMONIDINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CASPASE; CATALASE; FLUNARIZINE; GINKGO BILOBA EXTRACT; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; NEUROTROPHIN; NIFEDIPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BCL 2; PROTEIN P53; SELEGILINE; SUPEROXIDE DISMUTASE;

APOPTOSIS; CALCIUM CELL LEVEL; CELL HYPOXIA; CLINICAL TRIAL; DRUG MECHANISM; DRUG USE; GENE DELIVERY SYSTEM; GENE THERAPY; GLAUCOMA; HUMAN; IMMUNOLOGY; MEDLINE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OPTIC NERVE DISEASE; RETINA GANGLION CELL; RETINA ISCHEMIA; REVIEW; STRESS;

EID: 0037869016     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: 10.4103/0022-3859.917     Document Type: Review

References (47)

1. Brubaker RF. Delayed functional loss in glaucoma. LII Edward Jackson Memorial Lecture. Am J Ophthalmol 1996;121:473-83.
2. Lisegang TJ. Glaucoma: changing concepts and future directions. Mayo Clin Proc 19967;689-94.
3. Osborne NN, Ugarte M, Chao M, Chidlow G, Bae JH, Wood JP, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol 1999;43(Suppl):102-28.
4. Quigley HA, Green WR. The histology of human glaucoma cupping and optic nerve damage: clinicopathologic correlation in 21 eyes. Ophthalmology 1979;86:1803-30.
5. Korth M, Horn F, Stork B, Jonas J. The pattern evoked electroretinogram: age related alterations and changes in glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:123-30.
6. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-49.
7. Wein FB, Levin LA. Current understanding of neuroprotection in glaucoma. Curr Opin Ophthalmol 2002;13:61-7.
8. Kerr JF, Wyilie AH, Currle AR. Apoptosis: a basic biologic phenomenon with wide-ranging complications in tissue kinetics. Br J Cancer 1972;26:239-57.
9. Faden AI. Pharmacotherapy in spinal cord injury: a critical review of recent developments. Clin Neuropharmacol 1987;10:193-204.
10. Lynch DR, Dawson TM. Secondary mechanisms in neuronal trauma. Curr Opin Neurol 1994;7:510-6.
11. Choi DA. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-34.
12. Siesjo BK. Mechanisms of ischaemic brain damage. Crit Care Med 1988;16:954-63.
13. Yoles E, Schwartz M. Potential neuroprotective therapy for glaucomatous optic neuropathy. Surv Ophthalmol 1998;42:367-72.
14. Neufield AH. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. J Glaucoma 1998;7:434-8.
15. Mckinnon SJ. Glaucoma, apoptosis and neuroprotection. Curr Opin Ophthalmol 1997;8:28-37.
16. Nickells RW. Retinal ganglion cell death in glaucoma: the how, the witty and the maybe. J Glaucoma 1996;5:345-56.
17. Nickells RW, Zack DJ. Apoptosis in ocular disease: a molecular review. Ophthalmic Genet 1996;17:145-65.
18. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zach DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vi Sci 1995;36:774-86.
19. Gao H, Qiaou X, Hefti F, Holyfield JG, Knusel.B. Elevated mRNA expression of brain-derived neurotrophic factor in retinal ganglion cell layer after optic nerve injury. Invest Ophthalmol Vis Sci 1997;38:1840-7.
20. Naskar R, Dreyer EB. New horizons in neuroprotection. Surv Ophthlamol 2001;45(Suppl 3):S250-6.
21. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973;134:707-16.
22. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection and retinal ganglion cell death: An overview. Int Ophthalmol Clin 2001;41:111-30.
23. Kaufman PL, Gabelt BT, Cynader M. Introductory comments on neuroprotection. Surv Ophthalmol 1999;43(Suppl):S89-90.
24. Schwartz M, Belkin M, Yoles E, Solomon A. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration. J Glaucoma 1996;5:427-32.
25. Chew SJ, Ritch R. Neuroprotection: the next break through in glaucoma? Proceedings of the third Annual Optic Nerve Rescue and Restoration Think Tank. J Glaucoma 1997;6:263-66.
26. Wheeler LA, Gil DW, WoldeMussie E. Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma. Surv Ophthalmol 2001;45(Suppl)3:S290-6.
27. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low tension and open angle glaucoma. Am J Ophthalmol 1993;115:608-13.
28. 2+ antagonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 1989;227:408-12.
29. Eschweiler GW, Bahr M. Flunarizine enhances rat retinal ganglion cell survival after axotomy. J Neurol Sci 1993;116:34-40.
30. Caprioli J. Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol Scand 1997;75:364-7.
31. Bautista RD. Glaucomatous neurodegeneration and the concept of neuroprotection. Int Ophthalmol Clin 1999;39:57-70.
32. Gross RL, Hensley SH, Gao F, Wu SM. Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Surv Ophthalmol 1999;43(Suppl 1):S162-70
33. Gao H, Qiao X, Cantour LB, Wu Dunn D. Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch Ophthalmol 2002;120:797-803.
34. Vorwerk CK, Lipton SA, Zurakowski D, Hyman BT, Sobel BA, Dreyer EB. Chronic low-dose glutamate is toxic to retinal ganglion cells: toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996;37:1618-24.
35. Lagreze WA, Knorle R, Bach M, Feuerstein TJ. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 1998;39:1063-6.
36. Neufeld AH, Sawada A, Becker B. Inhibition of nitric oxide synthase-2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Nat Acad Sci USA 1999;96:9944-8.
37. Rabacchi SA, Ensini M, Bonfanti I, Grarina A, Maffei L. Nerve growth factor reduces apoptosis of axotornized retinal ganglion cells in the neonatal rat. Neuroscience 1994;63:969-73.
38. Ritch R. Neuroprotection: Is it already applicable to glaucoma therapy?. Curr Opin Ophthalmol 2000;11:78-84.
39. Janssens D, Michiels C, Delaive E, Eliaers F, Drieu K, Remacle J. Protection of hypoxia induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide. Biochem Pharmacol 1995;50:991-9.
40. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increased ocular blood flow velocity. J Ocul Pharmacol Ther 1999;15:233-40.
41. Sood NN, Sood D. Primary glaucomas: current concepts and management. J Indian Med Assoc 2000;98:763-7.
42. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA 1998;279:300-7.
43. Garriell Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell-death in situ via labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
44. Adams JM, Cory S. The Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Science 1998;281:1322-6.
45. Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol 1999;43:S151-61.
46. Martinou JC, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski M, Missotten M, et al. Overexpression of Bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994;13:1017-30.
47. Lam TT, Fu J, Hyrnewycz M, Tso MO. The effect of aurintricarboxylic acid, an endonuclease inhibitor, on ischemia/ reperfusion damages in rat retina. J Ocular Pharmacol Ther 1995;11:253-9.